Chester L. Bowen

752 citations
27 papers · 593 indexed · h-index 13

Chester L. Bowen

26 papers receiving 568 citations

Peers

Chester L. Bowen
Comparison fields: 5 of 86
  • Immunology 200
  • Spectroscopy 137
  • Analytical Chemistry 53
  • Oncology 102
  • Clinical Biochemistry 25
Replace Naiyu Zheng with:
Naiyu Zheng United States
Patricia Zane United States
Hermes Licea‐Perez United States
Carola W.N. Damen Netherlands
Joachim Schuhmacher Germany
Jonathan Kehler United States
Catharina Crone Germany
Victoria L. Elliott United Kingdom
Joe Palandra United States
Chester L. Bowen relative to Naiyu Zheng United States Naiyu Zheng's profile →
Citations per field
00.5×1.5×
Naiyu Zheng · 1×
Citations per year

Countries citing papers authored by Chester L. Bowen

Since Specialization
Citations

This map shows the geographic impact of Chester L. Bowen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chester L. Bowen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chester L. Bowen more than expected).

Fields of papers citing papers by Chester L. Bowen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chester L. Bowen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chester L. Bowen. The network helps show where Chester L. Bowen may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Chester L. Bowen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Chester L. Bowen Line = papers co-authored together Chester L. Bowen links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20186
2 20166
3 201511
4 20152
5 201515
6 20149
7 201312
8 20139
9 201222
10 201095
11 201028
12 201033
13 200950
14 200951
15 200863
16 200740
17 20055
18 20044
19 20043
20 20041

About Chester L. Bowen

Chester L. Bowen is a scholar working on Immunology, Analytical Chemistry and Oncology, having authored 27 papers that have together received 593 indexed citations. Recurring topics across this work include Biosimilars and Bioanalytical Methods (8 papers), Cancer Treatment and Pharmacology (5 papers), Colorectal Cancer Treatments and Studies (4 papers), Protein purification and stability (4 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers), Metabolomics and Mass Spectrometry Studies (2 papers), Analytical chemistry methods development (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). The work is most often cited by research in Immunology (200 citations), Spectroscopy (137 citations) and Analytical Chemistry (53 citations). Chester L. Bowen has collaborated with scholars based in United States, United Kingdom and India. Frequent co-authors include Christopher A. Evans, Hermes Licea‐Perez, Sherry S. Wang, Jonathan Kehler, Justin M. Wiseman, Joseph H. Kennedy, Eric Yang, Lakshmi Vasist, Alison Reid and L. Rhoda Molife. Their work appears in journals such as Journal of Clinical Oncology, Antimicrobial Agents and Chemotherapy and British Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026